TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01736410 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04219722 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03565211 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01475188 — Predictive Biomarker (PRD): ZAP70 mRNA
Genes: ZAP70; SRK
Study NCT03599908 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00240656 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00240656 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03949738 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03945565 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02060656 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT03846297 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02049671 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02612714 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT02612714 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02612714 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02612714 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04705038 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03846362 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT03834584 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study NCT02658409 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT04007029 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01030718 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01030718 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00170963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02064218 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04991428 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04488107 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01960075 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT01960075 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00006669 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04037566 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03451825 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00016055 — Safety Biomarker (SAF): Interleukin 12
Study NCT00174057 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study NCT00174057 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01638195 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02681887 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02681887 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02681887 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01491074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02007239 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02007239 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT02007239 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02988986 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02988986 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02988986 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01371370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04524975 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02499458 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT02499458 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02351986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04392011 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04392011 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03811054 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03811054 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study NCT03811054 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04519762 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00641147 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT03445806 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT02935257 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00500305 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04655586 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00341705 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01799382 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01799382 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04983212 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00427661 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03477630 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01040832 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT05506371 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT05506371 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT04372589 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01396330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02430792 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03778255 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT02267577 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02172222 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00005486 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT01370005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001269 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00310245 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02893254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00493389 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01785784 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03493503 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT03158259 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03158259 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT00782002 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03579823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00329940 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01727778 — Predictive Biomarker (PRD): HSPA5 mRNA
Genes: HSPA5; GRP78
Study NCT01727778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03336840 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01070303 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03960021 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03960021 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT03741608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01947673 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01765803 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00404924 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00404924 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01197209 — Predictive Biomarker (PRD): DKK3 mRNA
Genes: DKK3; REIC; UNQ258/PRO295
Study NCT04509856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03192878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01269125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00999921 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03977428 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00423748 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01326962 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02983838 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02983838 — Safety Biomarker (SAF): BDNF
Study NCT01065129 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00410722 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00410722 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02352376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01907438 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01907438 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02068339 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02099461 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02984644 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03667677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00390234 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03455179 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02199522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04552730 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02789332 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02789332 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02789332 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02789332 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT01195077 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04061473 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04061473 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04025281 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01950910 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01950910 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00729300 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT00234260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00201331 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02711345 — Predictive Biomarker (PRD): DUSP6 mRNA
Genes: DUSP6; MKP3; PYST1
Study NCT02571036 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT00739596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03813823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03813823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03813823 — Safety Biomarker (SAF): Interleukin 1
Study NCT03813823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03845049 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04045223 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02634164 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02076815 — Surrogate Endpoint (SUR): Platelet count response
Study NCT03915184 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03928002 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03928002 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04194593 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT04194593 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04194593 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT03352843 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01993784 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01993784 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02557945 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study NCT04085367 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT02440802 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study NCT02440802 — Predictive Biomarker (PRD): CYP1B1 mRNA
Genes: CYP1B1
Study NCT02440802 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study NCT02440802 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HSD3B1 mRNA
Genes: HSD3B1; 3BH; HSDB3A
Study NCT02440802 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02440802 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02440802 — Predictive Biomarker (PRD): ESRRG mRNA
Genes: ESRRG; ERR3; ERRG2; KIAA0832; NR3B3
Study NCT02440802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02440802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01784549 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT01784549 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT01784549 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01784549 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03687034 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05517512 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT05720481 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03801161 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02705079 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03435640 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT03690258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00315484 — Surrogate Endpoint (SUR): Hematologic response
Study NCT00312377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00312377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00312377 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00312377 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04579393 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01516294 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02622360 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT01810965 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT03447184 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT03447184 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03611114 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03611114 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02981732 — Predictive Biomarker (PRD): CLCF1 mRNA
Genes: CLCF1; BSF3; CLC; NNT1
Study NCT02981732 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02592317 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02592317 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02592317 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02705859 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00005132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00298363 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03816163 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT02827565 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02827565 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02827565 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00998764 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02652429 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02240498 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03795610 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04536298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02495077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02377128 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02973607 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00836160 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01616758 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01616758 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04203212 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00312351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04551144 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02428985 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00176722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03210077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03996122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01224353 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT03541447 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT02432261 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study NCT02803372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02803372 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00292916 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02229149 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02359643 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01764503 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02792413 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT02792413 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02792413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02792413 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01001533 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00883844 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00481013 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00481013 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02594332 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT03334370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02917863 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT00634686 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01841034 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT03866525 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02229032 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT03345212 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03345212 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02254798 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04129502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04129502 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02937974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02937974 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02937974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02937974 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT04035837 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00990275 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT01205178 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00200928 — Predictive Biomarker (PRD): SLC11A1 mRNA
Genes: SLC11A1; LSH; NRAMP; NRAMP1
Study NCT01618656 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study NCT03215472 — Surrogate Endpoint (SUR): Blood pressure